121 related articles for article (PubMed ID: 7152443)
21. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
22. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
Bollag W
Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076
[No Abstract] [Full Text] [Related]
23. Evaluation of bone marrow toxic reaction in patients treated with allopurinol.
Stolbach L; Begg C; Bennett JM; Silverstein M; Falkson G; Harris DT; Glick J
JAMA; 1982 Jan; 247(3):334-6. PubMed ID: 7033573
[No Abstract] [Full Text] [Related]
24. [Mechanism of the action of allopurinol].
Pikhlak EG; Piliaev VG
Sov Med; 1981; (10):111-4. PubMed ID: 7031905
[No Abstract] [Full Text] [Related]
25. The current status of cancer chemotherapy for selected human neoplasms.
Rubin RN
Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
[No Abstract] [Full Text] [Related]
26. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
27. [Treatment-induced complications and frequent errors in cytostatic therapy].
Senn HJ
Schweiz Med Wochenschr; 1978 Aug; 108(32):1216-22. PubMed ID: 675216
[No Abstract] [Full Text] [Related]
28. Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
de Lemos ML; Taylor SC; Barnett JB; Hu F; Levin A; Moravan V; O'Reilly SE
J Oncol Pharm Pract; 2006 Dec; 12(4):193-9. PubMed ID: 17156591
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of hyperuricemia].
Sailer D
Med Klin; 1981 Feb; 76(5):142-3. PubMed ID: 7219341
[No Abstract] [Full Text] [Related]
30. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
Panomvana D; Sripradit S; Angthararak S
J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
[TBL] [Abstract][Full Text] [Related]
31. [Combined cytostatic treatment of non-Hodgkin's malignant lymphoma].
Japa J; Singer Z; Dzieza-Lalowicz I; Rozek-Lesiak K; Kardaszewicz S; Hołowiecki J; Harbut-Gryłka A; Stella-Hołowiecka B
Pol Tyg Lek; 1979 Mar; 34(10):377-80. PubMed ID: 440995
[No Abstract] [Full Text] [Related]
32. Hereditary nephropathy associated with hyperuricemia and gout.
Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of asymptomatic hyperuricemia].
Floege J
Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
[No Abstract] [Full Text] [Related]
34. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
35. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
36. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
37. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
Imataki O; Aoyama T; Tamai Y; Kawakami K
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1633-6. PubMed ID: 17940379
[TBL] [Abstract][Full Text] [Related]
38. [Myelomatosis and low level of vitamin B12].
Heyerdahl F; Kildahl-Andersen O
Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4321-2. PubMed ID: 10667130
[TBL] [Abstract][Full Text] [Related]
39. [Life-threatening hyperuricemia during cytostatic leukemia therapy].
Schwenk HU; Schneider U
Fortschr Med; 1982 Mar; 100(11):454-8. PubMed ID: 6951795
[TBL] [Abstract][Full Text] [Related]
40. Renal effects of low dose aspirin in elderly patients.
Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
